Walk into a dispensary and one number can quickly dominate the conversation: THC percentage. A flower labelled 28% may appear automatically superior to one marked 18%, particularly when the stronger option costs more. Yet cannabis quality is not a horsepower contest. Potency matters, but it cannot fully describe aroma, flavour, freshness, cultivation, balance or how an individual patient may respond.
Selecting flower purely by the largest number can be an expensive mistake. It is one part of a richer profile. At Cloud Nine, patients can explore different cannabinoid levels, genetics and aromatic characteristics rather than treating the menu like a leaderboard.
THC, or delta-9-tetrahydrocannabinol, is the principal intoxicating cannabinoid associated with cannabis. On dried flower, THC percentage usually represents the concentration of THC by weight, often with the potential conversion of THCA into THC included in the reported total.
As a simplified example, flower reported at 20% total THC contains approximately 200 milligrams of potential THC per gram. It does not mean that a patient will absorb all 200 milligrams.
Health Canada’s guide to reading cannabis labels explains how total THC and CBD may be displayed by weight, unit or total package amount. Thailand has its own regulatory system, but the explanation demonstrates why a percentage describes concentration rather than guaranteeing a particular experience.
It is also important to distinguish THC from THCA, a precursor that converts into THC when heated. Laboratories account for that conversion when calculating “total THC,” so reports may show several cannabinoid figures.
Generally, more THC can increase the potential for stronger intoxicating effects. But the relationship is not perfectly linear. Doubling the THC percentage does not guarantee an experience that feels exactly twice as strong.
The amount used, individual tolerance, metabolism and other compounds in the flower can all affect the result. Two people may respond differently to the same product.
Research also suggests that extremely potent products do not necessarily create proportionally greater subjective intoxication. A study published in JAMA Psychiatry found that concentrate users had much higher blood THC levels than flower users without reporting correspondingly greater intoxication. That study did not prove that potency is irrelevant; it showed why one laboratory number cannot predict the entire human experience.
Higher potency can also increase unwanted effects, particularly for inexperienced consumers. The US Centers for Disease Control and Prevention notes that cannabis can cause anxiety, paranoia and disorientation.
The central misconception is simple: potency and quality are treated as synonyms. They are not.
A technically strong flower can still be poorly grown, harshly dried or badly stored. Conversely, a moderately potent cultivar can be beautifully cultivated, fragrant and better suited to an individual patient.
Quality may involve reliable genetics, careful cultivation, clean handling, appropriate drying and curing, freshness, correct storage, an expressive terpene profile, accurate documentation and suitability for the individual patient.
Cloud Nine’s flower is grown through OG Farms, its GACP-certified cultivation facility in Chiang Mai. That origin and production story matters because a percentage alone says nothing about the care taken before the sample reached a laboratory.
It is like judging wine only by alcohol content: the number answers one question while leaving many others untouched.
Cannabis contains far more than THC. Terpenes contribute citrus, pine, floral, earthy, spicy and fuel-like characteristics. Minor cannabinoids also form part of the chemical profile.
The interaction between terpenes and THC is often discussed as the proposed “entourage effect,” but marketing frequently runs ahead of evidence. A review indexed by the US National Library of Medicine found limited evidence for predictable terpene-cannabinoid synergy.
What can be said safely is that a rich aroma and enjoyable character are not expressed by one potency figure. Someone comparing Runtz at 25.05% THC with Platinum Dolato at 14.50% THC is comparing different genetics and aromatic qualities—not merely two numbers.
Cloud Nine’s wider Asoke menu demonstrates that worthwhile flower exists across a range of reported strengths. The best choice is not automatically the entry sitting at the top of the numerical pile.
Laboratory testing is essential, but plant material is naturally variable. Sampling, handling, moisture and laboratory methodology can all influence a reported potency figure.
A 2025 study of 277 commercial products found that only 56.7% of the tested flower products fell within 15% of their labelled potency. Observed potency was generally lower than the label stated. The peer-reviewed study is available through PubMed, and its authors called for more consistent independent verification.
Storage adds another complication. Health Canada reports that THC can degrade through exposure to light, heat and oxygen. A result records a sample at one point in time; it does not freeze the flower chemically forever.
Certificates of analysis remain valuable evidence, but responsible interpretation still matters.
When buyers demand only the strongest flower, the market has an incentive to reward inflated claims and neglect other qualities. A dramatic THC percentage becomes easier to sell than cultivation standards, careful curing or a nuanced aromatic profile.
Number chasing can make customers overlook flower better suited to their tolerance, encourage producers to optimise for one laboratory result and turn labels into marketing weapons. Most importantly, patients may confuse maximum potency with medical suitability.
Genetics such as Tangie, Headband and Moonshine offer distinct aromatic identities. Reducing them to potency figures is like choosing music by volume alone.
The answer is not to ignore potency. The smarter approach is to place it in context.
First, consider personal tolerance and the practitioner’s instructions. High THC cannabis may be inappropriate for a new or sensitive patient. The authorised form and quantity are medical decisions, not retail upgrades.
Second, ask about genetics and aroma. Preferences for citrus, fruit, earth, pine or dessert-like characteristics can separate an impressive label from genuinely suitable flower.
Third, consider source, freshness and documentation. Ask whether the flower is traceable, how it was stored and whether laboratory information is available. Cloud Nine displays strain information and certificates of analysis where available.
Finally, compare realistic alternatives. MAC1 at 24.88% THC may appeal to an experienced patient, while lower-potency flower may provide a gentler option. The decision must remain within the prescription and professional guidance.
No. A higher THC percentage indicates greater potential THC concentration, not universally better flower. Genetics, terpenes, freshness, cultivation, storage, personal tolerance and medical suitability also matter.
There is no universal threshold that suits every market or patient. Flower above 20% is commonly described commercially as potent, but labels and individual responses vary. Treat categories such as “high THC” as broad descriptions rather than guarantees.
Yes. Different genetics, terpene profiles, minor cannabinoids, freshness and individual circumstances can contribute to different experiences even when the reported THC percentage is similar.
Not necessarily. Medical suitability depends on the patient, symptoms, risks, treatment plan and practitioner’s judgment. Higher potency can also increase unwanted effects. Patients should follow the authorised prescription rather than selecting purely by strength.
Yes. A certificate can provide useful information about cannabinoid testing and, depending on its scope, other laboratory results. It should be considered alongside traceability, storage and professional guidance.
The clearest answer is that THC percentage matters, but it does not decide whether cannabis flower is good. It estimates one part of potency while leaving out cultivation, curing, freshness, aroma, balance and individual suitability.
Cloud Nine gives eligible patients the opportunity to compare properly documented flower at its Asoke and Surawong locations. Products are supplied in person only to adults aged 20 or over with a valid prescription from a licensed Thai Traditional Medicine practitioner. Approval is not guaranteed, and the practitioner determines whether cannabis is appropriate.
Look at the number, but do not become hypnotised by it. The most expensive or numerically strongest flower is not automatically the best choice. A better decision considers the complete flower, the available evidence and the needs of the individual patient.
Medical disclaimer: This article provides general educational information and is not medical advice. Cannabis can cause adverse effects and may interact with medication or existing health conditions. Consult a qualified practitioner and follow the prescription issued for your individual circumstances.
Legal disclaimer: Cannabis regulations in Thailand can change. This article reflects the position at the time of publication and is not legal advice. Cannabis flower is available only through the lawful medical framework and must not be taken across an international border.